QNTM — Quantum BioPharma Balance Sheet
0.000.00%
Last trade - 00:00
- CA$11.58m
- CA$6.88m
- 23
- 44
- 14
- 16
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | fx Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 6.11 | 17.5 | 35.4 | 17 | 3.51 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1.59 | 0.161 | 0.501 | 0.374 | 7.42 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 8.76 | 26.9 | 45.9 | 17.9 | 11.1 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 9.19 | 0 | 0.168 | 0.261 | 0.12 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Total Assets | 44.2 | 42 | 63 | 38.4 | 17.5 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 6.99 | 5.58 | 8.7 | 7.83 | 4.57 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Liabilities | 7.1 | 5.66 | 8.83 | 7.87 | 4.24 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 37.1 | 36.3 | 54.1 | 30.5 | 13.2 |
Total Liabilities & Shareholders' Equity | 44.2 | 42 | 63 | 38.4 | 17.5 |
Total Common Shares Outstanding |